Get started
Ascendis Pharma A/SAscendis Pharma A/SAscendis Pharma A/S

Ascendis Pharma A/S

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsBonds
Full chart
Full chart

Compare with Ascendis Pharma A/S



Key stats


Market capitalization
‪16.28 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
28.37
Basic EPS (TTM)
9.40 USD
Net income (FY)
‪−257.35 M‬ USD
Revenue (FY)
‪812.73 M‬ USD
Shares float
‪61.56 M‬
Beta (1Y)
0.26

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Profile


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Jan Møller Mikkelsen
Website
ascendispharma.com
Headquarters
Hellerup
Founded
2006
IPO date
Jan 28, 2015
ISIN
DK0060615755
FIGI
BBG007R7VNC1
Identifiers
ISIN DK0060615755
CFI code
ESVUFB
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of ASND is 255.50 USD — it has increased by 1.11% in the past 24 hours. Watch Ascendis Pharma A/S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ascendis Pharma A/S stocks are traded under the ticker ASND.
ASND stock has fallen by −4.23% compared to the previous week, the month change is a 8.97% rise, over the last year Ascendis Pharma A/S has showed a 49.56% increase.
We've gathered analysts' opinions on Ascendis Pharma A/S future price: according to them, ASND price has a max estimate of 354.96 USD and a min estimate of 248.71 USD. Watch ASND chart and read a more detailed Ascendis Pharma A/S stock forecast: see what analysts think of Ascendis Pharma A/S and suggest that you do with its stocks.
ASND reached its all-time high on Jul 9, 2026 with the price of 282.15 USD, and its all-time low was 11.92 USD and was reached on Jun 7, 2016. View more price dynamics on ASND chart.
See other stocks reaching their highest and lowest prices.
ASND stock is 2.84% volatile and has beta coefficient of 0.26. Track Ascendis Pharma A/S stock price on the chart and check out the list of the most volatile stocks — is Ascendis Pharma A/S there?
Today Ascendis Pharma A/S has the market capitalization of ‪16.14 B‬, it has decreased by −1.59% over the last week.
Yes, you can track Ascendis Pharma A/S financials in yearly and quarterly reports right on TradingView.
Ascendis Pharma A/S is going to release the next earnings report on Aug 6, 2026. Keep track of upcoming events with our Earnings Calendar.
ASND earnings for the last quarter are 11.26 USD per share, whereas the estimation was 0.19 USD resulting in a ‪5.91 K‬% surprise. The estimated earnings for the next quarter are 1.70 USD per share. See more details about Ascendis Pharma A/S earnings.
Ascendis Pharma A/S revenue for the last quarter amounts to ‪284.92 M‬ USD, despite the estimated figure of ‪308.93 M‬ USD. In the next quarter, revenue is expected to reach ‪372.79 M‬ USD.
ASND net income for the last quarter is ‪736.28 M‬ USD, while the quarter before that showed ‪−39.06 M‬ USD of net income which accounts for 0.00% change. Track more Ascendis Pharma A/S financial stats to get the full picture.
No, ASND doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ascendis Pharma A/S EBITDA is ‪13.51 M‬ USD, and current EBITDA margin is −16.47%. See more stats in Ascendis Pharma A/S financial statements.
Like other stocks, ASND shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ascendis Pharma A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ascendis Pharma A/S technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ascendis Pharma A/S stock shows the buy signal. See more of Ascendis Pharma A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.